United Neuroscience to Present at the 20th Annual Meeting of the American Society for Experimental Neurotherapeutics
DUBLIN, Feb. 28, 2018 /PRNewswire/ -- United Neuroscience, Ltd., (UNS), today announced that the company will present at the upcoming 20th Annual Meeting of the American Society for Experimental Neurotherapeutics (ASENT) conference being held March 7-10, 2018. Presentation details are as follows:
Symposium presentation: |
Active immunotherapy vaccines for CNS disorders |
Presenter: |
Ajay Verma, M.D., Ph.D., Chief Medical Officer |
Date: |
Friday, March 9, 2018 |
Time: |
10:15 a.m. EST |
Poster presentation: |
A Phase 2a, randomized, double-blind, placebo-controlled, 3-arm parallel-group, multicenter study with active immunotherapeutic vaccine UB-311 in patients with mild Alzheimer's disease |
Time: |
Thursday, March 8, 3:45 p.m. EST and Friday, March 9, 4:15 p.m. EST |
Location: |
Hilton Washington D.C./Rockville Hotel, Rockville, MD |
About United Neuroscience
United Neuroscience (UNS) is a clinical-stage biotech company dedicated to the development of best-in-class immunotherapeutics for the brain. A global company headquartered in Dublin, Ireland, with operations in Taiwan and the United States, UNS was founded to address the social and economic burden of Alzheimer's and other neurodegenerative diseases and seeks to rapidly advance candidates into and through clinical trials with the goal of delivering breakthrough treatments to patients. For more information please visit www.unitedneuroscience.com. Follow UNS on Twitter at https://twitter.com/UNSTechBio and on LinkedIn at www.linkedin.com/company/unitedneuroscience.
Media Contacts
David Schull or Rich Allan
Russo Partners, LLC
(212) 845-4271
(646) 942-5588
[email protected]
[email protected]
SOURCE United Neuroscience, Ltd.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article